Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jul 13, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the second quarter of 2017 on August 3, 2017 after t...
Jun 12, 2017
Strong results show potential for Horizon to improve clinical outcomes in pediatric and adolescent age groups with type 1 diabetes BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its ...
Jun 9, 2017
Company Further Demonstrates Significant Impact on Improving the Quality of Life of People with Diabetes BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin ...
Jun 5, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on Tues...
Jun 2, 2017
PDF
May 30, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced the appointment of Bret Christensen as Chief Commercial Officer. Mr. Christensen will run the C...
May 25, 2017
Leader in Tubeless Insulin Pump Technology Ranks in Top Five Percent Among List of Most Innovative 100 Public Companies BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod...
May 8, 2017
First Quarter Revenue of $101.7 Million, up 25% Year-Over-Year, Exceeds Expectations Gross Margin Improves to 58.4% Insulet Raises Mid-Point of Full Year 2017 Revenue Guidance, Expecting Growth of 18%, and Introduces Second Quarter Growth Expectation of 21% ...
Apr 7, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the first quarter 2017 on May 8, 2017 after the clos...
Feb 27, 2017
Fourth Quarter Revenue of $103.6 Million, up 24% Year-Over-Year; Full Year 2016 Revenue of $367.0 Million, up 39% Year-Over Year, Exceeds Expectations Fourth Quarter Gross Margin Improves to 58.8%; Full Year 2016 Gross Margin Improves to 57.5% Insulet Expects Full Year 201...
Feb 17, 2017
First Feasibility Study on the Automated Glucose Control Algorithm Demonstrates Beneficial Results in Adults with Type 1 Diabetes BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its ...
Feb 15, 2017
Facility to Support Long-Term Growth Initiatives While Driving Increased Productivity and Quality BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin M...
Feb 13, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming investor conferences: ...
Jan 23, 2017
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year 2016 on February 27...
Dec 20, 2016
BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35th Annual J.P. Morgan Healthcare Conference in San Franci...